MedTech startup Smarterials Technology closes second seed financing round
Berlin, 28.09.2021 – Smarterials Technology develops surgical gloves based on innovative materials with a double barrier function and perforation indicator that help reduce the risk of injury and infection among healthcare workers. This novel product helps to avoid follow-up costs due to contamination with potentially infectious foreign blood – an estimated 500,000 cases with follow-up costs of up to 1,600 euros per case in Germany alone. In addition, the innovative double-layer gloves speed up the donning process and thus improve the workflow in hospitals and care facilities.
The team of Smarterials was also able to convince the EU Commission of its innovative product and is receiving grants of 1.85 million euros as part of the Horizon 2020 SME Instrument (Phase II) funding program.
A lot has happened in the medical glove market during the Corona pandemic. With the capital provided, we are able to take advantage of the dynamics of the situation and scale our product. Our Two-in-One Gloves replace the current safety standard while reducing the consumption of materials and energy and contributing to the conservation of natural resources. Our goal is to make Two-in-One Gloves the global standard in the surgical field.
Dr. Martin Bothe, co-founder and CEO of Smarterials Technology.
We believe in Smarterials‘ technology to be the future in safety gloves for medical personnel to provide safety for both doctors and patients. The perspective to address a mass market rather quickly was the final convincing argument for our investment.
Dr. Fabian Mohr, Senior Investment Manager at High-Tech Gründerfonds
